Literature DB >> 32286701

Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis.

Kedar R Mahajan1,2, Kunio Nakamura3, Jeffrey A Cohen1, Bruce D Trapp2, Daniel Ontaneda1.   

Abstract

OBJECTIVE: Thalamic atrophy is among the earliest brain changes detected in patients with multiple sclerosis (MS) and the degree of thalamic atrophy is a strong predictor of disability progression. The causes of thalamic atrophy are not fully understood. Here, we investigate the contributions of thalamic demyelinated lesions, thalamic neuronal loss, and cerebral white matter (WM) lesions to thalamic volume.
METHODS: We used postmortem in situ magnetic resonance imaging (MRI) scans of 95 subjects with MS to correlate thalamic lesion volumes with global MRI metrics. We histologically characterized thalamic demyelination patterns and compared neuronal loss and neuritic pathology in the thalami with the extremes of volume.
RESULTS: Grossly apparent thalamic discolorations in cm-thick brain slices were T2/fluid-attenuated inversion recovery (FLAIR) hyperintense, T1-hypointense, and appeared as perivascular demyelinated lesions with dystrophic neurons/axons. Subependymal demyelinated lesions with axonal loss and microglial/macrophage activation were also observed. The 12 subjects with the least thalamic volume had a 17.6% reduction of median neuronal density in the dorsomedial/ventrolateral and pulvinar nuclei compared with the 14 subjects with the greatest thalamic volume (p = 0.03). After correcting for age, disease duration, sex, and T2 lesion volume, the total (p = 0.20), ovoid (p = 0.31), or subependymal (p = 0.44) MRI thalamic lesion volumes correlated with thalamic volume. Thalamic volume correlated with cerebral T2 lesion volume (Spearman's rho = -0.65, p < 0.001; p < 0.0001 after correcting for age, disease duration, and sex).
INTERPRETATION: Our findings suggest the degeneration of efferent/afferent thalamic projections and/or a neurodegenerative process as greater contributors to thalamic atrophy than thalamic demyelinating lesions. ANN NEUROL 2020 ANN NEUROL 2020;88:81-92.
© 2020 American Neurological Association.

Entities:  

Mesh:

Year:  2020        PMID: 32286701      PMCID: PMC8291218          DOI: 10.1002/ana.25743

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

1.  Cortical lesions in multiple sclerosis.

Authors:  D Kidd; F Barkhof; R McConnell; P R Algra; I V Allen; T Revesz
Journal:  Brain       Date:  1999-01       Impact factor: 13.501

2.  Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.

Authors:  Massimiliano Calabrese; Francesca Rinaldi; Paola Grossi; Irene Mattisi; Valentina Bernardi; Alice Favaretto; Paola Perini; Paolo Gallo
Journal:  Mult Scler       Date:  2010-07-29       Impact factor: 6.312

3.  Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.

Authors:  Elias S Sotirchos; Natalia Gonzalez-Caldito; Blake E Dewey; Kathryn C Fitzgerald; Jeffrey Glaister; Angeliki Filippatou; Esther Ogbuokiri; Sydney Feldman; Ohemaa Kwakyi; Hunter Risher; Ciprian Crainiceanu; Dzung L Pham; Peter C Van Zijl; Ellen M Mowry; Daniel S Reich; Jerry L Prince; Peter A Calabresi; Shiv Saidha
Journal:  Mult Scler       Date:  2019-02-11       Impact factor: 6.312

4.  CLADA: cortical longitudinal atrophy detection algorithm.

Authors:  Kunio Nakamura; Robert Fox; Elizabeth Fisher
Journal:  Neuroimage       Date:  2010-07-30       Impact factor: 6.556

5.  Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.

Authors:  Athina Papadopoulou; Laura Gaetano; Armanda Pfister; Anna Altermatt; Charidimos Tsagkas; Felix Morency; Alexander U Brandt; Martin Hardmeier; Mallar M Chakravarty; Maxime Descoteaux; Ludwig Kappos; Till Sprenger; Stefano Magon
Journal:  Neurology       Date:  2019-04-10       Impact factor: 9.910

6.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

7.  Evidence of thalamic gray matter loss in pediatric multiple sclerosis.

Authors:  S Mesaros; M A Rocca; M Absinta; A Ghezzi; N Milani; L Moiola; P Veggiotti; G Comi; M Filippi
Journal:  Neurology       Date:  2008-02-13       Impact factor: 9.910

8.  Imaging correlates of axonal swelling in chronic multiple sclerosis brains.

Authors:  Elizabeth Fisher; Ansi Chang; Robert J Fox; Jean A Tkach; Therese Svarovsky; Kunio Nakamura; Richard A Rudick; Bruce D Trapp
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

9.  DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?

Authors:  Steven H P van de Pavert; Nils Muhlert; Varun Sethi; Claudia A M Wheeler-Kingshott; Gerard R Ridgway; Jeroen J G Geurts; Maria Ron; Tarek A Yousry; Alan J Thompson; David H Miller; Declan T Chard; Olga Ciccarelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-29       Impact factor: 10.154

10.  Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes.

Authors:  Isaiah Kletenik; Enrique Alvarez; Justin M Honce; Brooke Valdez; Timothy L Vollmer; Luis D Medina
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-02-13
View more
  13 in total

Review 1.  The role of glial cells in multiple sclerosis disease progression.

Authors:  Luke M Healy; Jo Anne Stratton; Tanja Kuhlmann; Jack Antel
Journal:  Nat Rev Neurol       Date:  2022-02-21       Impact factor: 44.711

2.  BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy.

Authors:  Rui Li; Hao Tang; Jeremy C Burns; Brian T Hopkins; Carole Le Coz; Bo Zhang; Isabella Peixoto de Barcelos; Neil Romberg; Amy C Goldstein; Brenda L Banwell; Eline T Luning Prak; Michael Mingueneau; Amit Bar-Or
Journal:  Acta Neuropathol       Date:  2022-03-18       Impact factor: 15.887

3.  Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis.

Authors:  Gabrielle M Mey; Kirsten S Evonuk; McKenzie K Chappell; Laura M Wolfe; Rupesh Singh; Julia C Batoki; Minzhong Yu; Neal S Peachey; Bela Anand-Apte; Robert Bermel; Daniel Ontaneda; Kunio Nakamura; Kedar R Mahajan; Tara M DeSilva
Journal:  Acta Neuropathol Commun       Date:  2022-06-15       Impact factor: 7.578

4.  Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray-white matter junction correlates with iron-enriched macrophages.

Authors:  Kedar R Mahajan; Moein Amin; Matthew Poturalski; Jonathan Lee; Danielle Herman; Yufan Zheng; Caroline Androjna; Mark Howell; Robert J Fox; Bruce D Trapp; Stephen E Jones; Kunio Nakamura; Daniel Ontaneda
Journal:  Mult Scler       Date:  2021-03-22       Impact factor: 5.855

Review 5.  Does Siponimod Exert Direct Effects in the Central Nervous System?

Authors:  Markus Kipp
Journal:  Cells       Date:  2020-07-24       Impact factor: 6.600

6.  T1 Relaxation Times in the Cortex and Thalamus Are Associated With Working Memory and Information Processing Speed in Patients With Multiple Sclerosis.

Authors:  Christian Thaler; Isabelle Hartramph; Jan-Patrick Stellmann; Christoph Heesen; Maxim Bester; Jens Fiehler; Susanne Gellißen
Journal:  Front Neurol       Date:  2021-12-03       Impact factor: 4.003

7.  Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis.

Authors:  Álvaro J Cruz-Gomez; Lucía Forero; Elena Lozano-Soto; Fátima Cano-Cano; Florencia Sanmartino; Raúl Rashid-López; Jsé Paz-Expósito; Jaime D Gómez Ramirez; Raúl Espinosa-Rosso; Javier J González-Rosa
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-08-31

8.  Smaller spared subcortical nuclei are associated with worse post-stroke sensorimotor outcomes in 28 cohorts worldwide.

Authors:  Sook-Lei Liew; Artemis Zavaliangos-Petropulu; Nicolas Schweighofer; Neda Jahanshad; Catherine E Lang; Keith R Lohse; Nerisa Banaj; Giuseppe Barisano; Lee A Baugh; Anup K Bhattacharya; Bavrina Bigjahan; Michael R Borich; Lara A Boyd; Amy Brodtmann; Cathrin M Buetefisch; Winston D Byblow; Jessica M Cassidy; Charalambos C Charalambous; Valentina Ciullo; Adriana B Conforto; Richard C Craddock; Adrienne N Dula; Natalia Egorova; Wuwei Feng; Kelene A Fercho; Chris M Gregory; Colleen A Hanlon; Kathryn S Hayward; Jess A Holguin; Brenton Hordacre; Darryl H Hwang; Steven A Kautz; Mohamed Salah Khlif; Bokkyu Kim; Hosung Kim; Amy Kuceyeski; Bethany Lo; Jingchun Liu; David Lin; Martin Lotze; Bradley J MacIntosh; John L Margetis; Feroze B Mohamed; Jan Egil Nordvik; Matthew A Petoe; Fabrizio Piras; Sharmila Raju; Ander Ramos-Murguialday; Kate P Revill; Pamela Roberts; Andrew D Robertson; Heidi M Schambra; Na Jin Seo; Mark S Shiroishi; Surjo R Soekadar; Gianfranco Spalletta; Cathy M Stinear; Anisha Suri; Wai Kwong Tang; Gregory T Thielman; Vincent N Thijs; Daniela Vecchio; Nick S Ward; Lars T Westlye; Carolee J Winstein; George F Wittenberg; Kristin A Wong; Chunshui Yu; Steven L Wolf; Steven C Cramer; Paul M Thompson
Journal:  Brain Commun       Date:  2021-10-27

9.  Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers.

Authors:  Matthias Bussas; Sophia Grahl; Viola Pongratz; Achim Berthele; Christiane Gasperi; Till Andlauer; Christian Gaser; Jan S Kirschke; Benedikt Wiestler; Claus Zimmer; Bernhard Hemmer; Mark Mühlau
Journal:  Mult Scler       Date:  2021-09-30       Impact factor: 5.855

10.  Volume reduction without neuronal loss in the primate pulvinar complex following striate cortex lesions.

Authors:  Jonathan M Chan; Katrina H Worthy; Marcello G P Rosa; David H Reser; Nafiseh Atapour
Journal:  Brain Struct Funct       Date:  2021-07-29       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.